IRCT2016100423559N5已完成未知
Evaluate the therapeutic effects Sevelamer to reduce blood sugar levels, HbA1c, blood lipids and hs-CRP in patients with diabetic nephropathy
Vice chancellor for research, Ardabil University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 years 至 no limit（—）
- 性别
- All
入选标准
- •Treated patients due to diabetic nephropathy with (6.5% And Age> 45 years
- •Exclusion criteria: Use of chemotherapy medications, presence of associated malignancy
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Evaluation the effect of adding Sevelamer to the standard treatment of aluminum phosphide poisoning patientsIRCT20210720051946N7Shahid Beheshti University of Medical Sciences60
撤回
不适用
Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)End-Stage Renal DiseaseInsulin ResistanceHyperphosphatemiaKidney Failure, ChronicNCT00837655Karolinska Institutet
已完成
4 期
Comparing the Effect of Sevelamer Hydrochloride and Calcium Carbonate on Serum Level of Inflammatory Markers in Hemodialysis PatientsIRCT20200724048193N1Tabriz University of Medical Sciences40
招募中
不适用
An Open Label, Dose Titration Study Of Sevelamer Carbonate Dosed Three Times A Day In Hyperphosphatemic Chronic Kidney Disease (CKD) Patients Not On DialysisHyperphosphatemia in CKD Patients not on DialysisRenal and Urogenital - Kidney diseaseACTRN12606000380594Genzyme Corporation, USA40
已完成
3 期
Reepaven effect on severity of pain and bleeding during menstruatioIRCT20140804018677N4Shahid Beheshti University of Medical Sciences80